Patients with therapeutic intensification of pharmacological pressure-unloading therapy had marked improvements in cardiac load, the study found, as demonstrated by reductions in N-terminal pro-B-type ...

To lead in this era, organizations must move beyond redundant sets of hardware and embrace a framework of infrastructure that ...

A deep molecular analysis of failing human hearts suggests diabetes may directly alter cardiac metabolism, but experts differ ...

Diabetes and kidney disease are major risk factors for heart disease, yet many cases are undiagnosed. In addition, a consumer survey done last fall suggests that most people don't realize that their ...

Del-desiran (also known as AOC1001) is an antibody-oligonucleotide conjugate comprised of a DMPK small interfering RNA (siRNA ...

Advancing chronic kidney disease may raise risk of cognitive decline, with attention, memory and brain function impacted, new JAMA study reveals.

A team led by Northwestern University and Shirley Ryan AbilityLab scientists have developed a new technology that can eavesdrop on the hidden electrical dialogues unfolding inside miniature, lab-grown ...

Dylan Jack Moran, 25, was told he had a 50 per cent of survival when he was diagnosed with kidney failure at the age of 23 in ...

High blood pressure exerts a powerful and often silent toll on the brain by damaging the complex network of blood vessels required for healthy cognitive function.

Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

As men age, many quietly lose the Y chromosome in some cells, and scientists now link this hidden change to heart disease, cancer and even shorter lifespans.

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.